Skip to main content
Premium Trial:

Request an Annual Quote

Natrix Separations Raises $19M in Series B Financing

NEW YORK (GenomeWeb News) – Natrix Separations, a Burlington, Ontario-based manufacturer of membrane-based disposable chromatography products, has raised $19 million in a Series B financing, the firm announced last night.
The firm said it would use the funds to complete construction of its ISO 900-compliant commercial manufacturing facility, and to support commercialization of its portfolio of separation products based on its adsept technology. That technology enables end users to rapidly and selectively capture specific target molecules from a broad range of feed streams, Natrix said.
The round of financing was led by Cupertino, Calif.-based DE Shaw Venture Capital and included existing investors Canadian Medical Discoveries Fund, which is managed by a unit of Jovian Capital, and BDC Venture Capital, which is the venture capital arm of the Business Development Bank of Canada.
As part of the financing, Alex Wong, a managing director of DE Shaw, will join Natrix’s board of directors.
“Natrix is a rare company that has created technology to enable a new generation of cost-effective, high performance products ranging from therapeutic drugs to nutraceuticals and ultrapure drinking water,” Wong said in a statement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.